Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1070862

CC(=O)c1cccc(C(C)=O)n1.CC1C=CC=C(Cl)C1=N.CC1C=CC=C(Cl)C1=N.[Cl-].[Cl-].[Fe+2]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MRGPRX4 Q96LA9 2/20 0.31
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1070626 0.97 KDM4E (0.34) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL7752375 0.96 KDM4E (0.35) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL1078463 0.87 KDM4E (0.34) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL1079384 0.85 ALDH1A1 (0.35) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL1071561 0.84 KDM4E (0.34) KDM4EALOX15TSHRACMSDTDP1
Bromide SCHEMBL933202 0.83 CYP1A2 (0.33) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL933207 0.81 CYP1A2 (0.33) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL2047916 0.78 ALDH1A1 (0.33) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL5082319 0.74 ALDH1A1 (0.34) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL5077945 0.74 ALDH1A1 (0.34) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513166-B1 PROCESS FOR THE PREPARATION OF SUPPORTED CATALYSTS BASELL POLYOLEFINE GMBH (DE) 2017-04-05 EP disclosed
EP-2134756-B1 CATALYST COMPOSITION AND POLYMERISATION PROCESS USING IT BASELL POLYOLEFINE GMBH (DE) 2015-06-10 EP disclosed
US-8859451-B2 Process for the preparation of supported catalysts BASELL POLYOLEFINE GMBH (DE) 2014-10-14 US disclosed
US-8759460-B2 Process for the polymerization of ethylene, and ethylene polymers having broad molecular weight distribution and long-chain branching BASSELL POLYOLEFINE GMBH (DE) 2014-06-24 US disclosed
US-8563674-B2 Polyethylene and catalyst composition for its preparation BASELL POLYOLEFINE GMBH (DE) 2013-10-22 US disclosed
EP-2177543-B1 Hybrid catalyst composition for polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2013-08-14 EP disclosed
EP-2225283-B1 MULTISTAGE PROCESS FOR THE POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2013-08-14 EP disclosed
US-8501884-B2 Polyethylene and catalyst composition and process for the preparation thereof BASELL POLYOLEFINE GMBH (DE) 2013-08-06 US disclosed
US-8435911-B2 Hybrid catalyst composition for polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2013-05-07 US disclosed
EP-2356155-B1 PROCESS FOR THE POLYMERIZATION OF ETHYLENE, AND ETHYLENE POLYMERS HAVING BROAD MOLECULAR WEIGHT DISTRIBUTION AND LONG- CHAIN BRANCHING BASELL POLYOLEFINE GMBH (DE) 2013-01-23 EP disclosed
WO-2005058983-A2 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2005-06-30 WO disclosed
EP-1539774-A1 MONOCYCLOPENTADIENYL COMPLEXES Basell Polyolefine GmbH (DE) 2005-06-15 EP disclosed
EP-1534724-A2 MONOCYCLOPENTADIENYL COMPLEXES Basell Polyolefine GmbH (DE) 2005-06-01 EP disclosed
US-20040249095-A1 Method of polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2004-12-09 US disclosed
WO-2004104052-A1 TRANSITION-METAL COMPLEXES WITH TRIDENTATE, NITROGEN-CONTAINING LIGANDS BASELL POLYOLEFINE GMBH (DE) 2004-12-02 WO disclosed
US-20040242880-A1 Monocyclopentadienyl complexes comprising a condensed heterocycle BASELL POLYOLEFINE GMBH (DE) 2004-12-02 US disclosed
WO-2004056482-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-07-08 WO disclosed
WO-2004056481-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-07-08 WO disclosed
WO-2004020479-A2 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-03-11 WO disclosed
WO-2004018489-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242880-A1 Monocyclopentadienyl complexes comprising a condensed heterocycle MCM4, MCM3, CCNC KDM4E 3332/4885ALOX15 1095/4885TSHR 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.